Correlation of Computed Tomography and Positron Emission Tomography in Patients With Metastatic Gastrointestinal Stromal Tumor Treated at a Single Institution With Imatinib Mesylate: Proposal of New ...
The mode of action of targeted cancer agents (TCAs) differs from classic chemotherapy, which leads to concerns about the role of RECIST in evaluating tumor response in trials with TCAs. We ...
(HealthDay News) – RECIST categories used to quantify tumor changes during exposure to anticancer therapies correlate well with overall survival (OS) but reflect a more linear continuum without clear ...
Most oncology trials, including TIGER-X, use a standard method to assess tumor response called the Response Evaluation Criteria in Solid Tumors (RECIST). 3 Under RECIST, a partial response must be ...
Outcomes among patients with stage IV non–small cell lung cancer as evaluated within clinical trials via Response Evaluation Criteria in Solid Tumors (RECIST) and clinician response criteria in ...
The Response Evaluation Criteria In Solid Tumors (RECIST), used in many clinical trials to evaluate changes in tumor burden over time, classify objective tumor response into one of four categories ...
Oncologists and researchers use a measurement known as Response Evaluation Criteria in Solid Tumors (RECIST) to evaluate the degree to which a patient's cancer responds to treatment during clinical ...
In 1963, 20 years after he first administered nitrogen mustard to a human, Yale pharmacologist Alfred Gilman recounted the previously top-secret clinical experiment for a surgical audience. He wrote: ...
CHICAGO -- FDA researchers found that when evaluating outcomes observed with immunotherapy drugs used in advanced melanoma, the depth of response (i.e., how much of the cancer is eliminated by ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results